Zobrazeno 1 - 10
of 46
pro vyhledávání: '"E. Yu. Pogozheva"'
Autor:
V. N. Amirjanova, A. E. Karateev, E. Yu. Pogozheva, E. S. Filatova, R. R. Samigullina, V. I. Mazurov, O. N. Anoshenkova, N. A. Lapkina, A. A. Baranov, T. Yu. Grineva, A. M. Lila, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 3, Pp 327-333 (2022)
The aim of the study was to evaluate the effectiveness of UPA in RA patients in real clinical practice after 3 and 6 months of therapy.Material and methods. The study included 63 RA patients with high activity of the disease. Activity was assessed ac
Externí odkaz:
https://doaj.org/article/5cc72e5d8cab4c76b31da0460442ceb8
Autor:
E. Yu. Pogozheva, A. E. Karateev, N. A. Bulgakova, V. N. Amirdzhanova, E. S. Filatova, V. A. Nesterenko, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 43-49 (2021)
Patient's satisfaction with treatment is a fundamental indicator of the quality of medical care, which is especially important for assessing the effectiveness of therapy for musculoskeletal pain in rheumatic diseases (RD).Objective: to determine sati
Externí odkaz:
https://doaj.org/article/18cacbe52a6d4123bc8035dce41f070b
Autor:
A. E. Karateev, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, L. I. Alekseeva, E. Yu. Pogozheva, E. S. Filatova, V. A. Nesterenko
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 3, Pp 255-262 (2021)
Combating the consequences of COVID-19, a disease caused by the new coronavirus infection SARS-CoV-2, is a serious and very urgent task facing modern medicine. COVID-19 often has a severe course and is accompanied by multiple organ damage, systemic i
Externí odkaz:
https://doaj.org/article/5bbd7d9e2fe34a7fb85b201ccc5b607e
Autor:
A. E. Karateev, E. L. Nasonov, E. Yu. Pogozheva, E. S. Filatova, V. N. Amirdzhanova, V. A. Nesterenko
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 3, Pp 302-315 (2021)
25 years ago, a new non-steroidal anti-inflammatory drug (NSAID) – meloxicam (Movalis®) – entered the clinical practice of our country. This drug was the first embodiment of the concept of selective blockade of cyclooxygenase 2 – the main path
Externí odkaz:
https://doaj.org/article/68ba7456e0f0435987eb420c19f891c4
Publikováno v:
Современная ревматология, Vol 15, Iss 2, Pp 57-63 (2021)
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to control pain in rheumatoid arthritis (RA). However, many aspects of the therapeutic effect of NSAIDs in RA have not been sufficiently studied. In particular, this concerns the effect of
Externí odkaz:
https://doaj.org/article/1b01ed02ab834cedb7bd57decdd9e072
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 138-143 (2020)
Effective pain relief in rheumatology practice is one of the most important criteria for the quality of medical care. Therefore, drugs with analgesic effects, primarily nonsteroidal anti-inflammatory drugs (NSAIDs), are among the most commonly used o
Externí odkaz:
https://doaj.org/article/13fcf076a1bb4deab5bae0a607785194
Autor:
A. E. Karateev, E. Yu. Pogozheva, E. S. Filatova, A. M. Lila, V. N. Amirdjanova, V. A. Nesterenko
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 4, Pp 387-394 (2020)
Diclofenac Potassium sachets (DPS) is a new faster-absorption and rapid onset of pain relief drug dosage form of Diclofenac with high analgesic potential.Objective. To assess efficacy and safety of Diclofenac sachets and intramuscular injections in r
Externí odkaz:
https://doaj.org/article/8fd8d1491dbb4647b65de0d5b5f1ef33
Publikováno v:
Современная ревматология, Vol 14, Iss 2, Pp 90-96 (2020)
Analysis of the results of clinical trials should be based on the use of objective parameters that allow for assessing the significance of the data obtained for real medical practice. These parameters include Minimal Clinically Important Improvement
Externí odkaz:
https://doaj.org/article/6e9ac9dc185b404b824643aff0f7c76b
Autor:
L. I. Alekseeva, A. E. Karateev, E. Yu. Pogozheva, V. N. Amirdzanova, E. S. Filatova, V. A. Nesterenko
Publikováno v:
Современная ревматология, Vol 14, Iss 2, Pp 76-83 (2020)
Glycosaminoglycan-peptide complex (GPC) is a popular injectable extended-release symptomatic agent (ERSA) in Russia for the treatment of osteoarthritis (OA). To date, no large-scale studies of GPC used in real clinical practice have been conducted in
Externí odkaz:
https://doaj.org/article/6bae5918b89141f0b3558af59c615405
Autor:
A. E. Karateev, E. S. Filatova, E. Yu. Pogozheva, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, V. I. Mazurov, A. Yu. De, A. A. Baranov, N. A. Lapkina, G. V. Lukina, N. A. Kiryukhina, S. Yu. Davidyan, T. S. Salnikova, R. R. Samigullina, D. S. Chakieva, I. M. Marusenko, O. V. Semagina, M. Yu. Semchenkova, A. F. Davydova, E. V. Kalinina
Publikováno v:
Современная ревматология, Vol 14, Iss 2, Pp 69-75 (2020)
Janus kinase (JK) inhibitors block the intracellular signaling pathways that are responsible for the synthesis of proinflammatory cytokines and mediators, which in turn cause the activation of pain receptors and central sensitization (CS). It is sugg
Externí odkaz:
https://doaj.org/article/af84c1d6e4e34c688e41f9ab87acd8f6